Ortho-Substituted C-aryl Glucosides As Highly Potent and Selective Renal Sodium-dependent Glucose Co-transporter 2 (SGLT2) Inhibitors
Overview
Chemistry
Authors
Affiliations
A series of 2-substituted C-aryl glucosides have been synthesized and evaluated for inhibition of hSGLT1 and hSGLT2. Introduction of an appropriate ortho substituent at the proximal phenyl ring adjacent to the glycosidic bond was found to improve SGLT2 inhibitory activity and dramatically increase selectivity for hSGLT2 over hSGLT1. Selected compounds were investigated for in vivo efficacy.
Sharma S, Kumar S, Gupta J, Mittal A, Khurana N Future Med Chem. 2025; 17(4):409-423.
PMID: 39935011 PMC: 11834423. DOI: 10.1080/17568919.2025.2463869.
Maccari R, Ottana R J Med Chem. 2022; 65(16):10848-10881.
PMID: 35924548 PMC: 9937539. DOI: 10.1021/acs.jmedchem.2c00867.
SGLT inhibitors as antidiabetic agents: a comprehensive review.
Kshirsagar R, Kulkarni A, Chouthe R, Pathan S, Une H, Reddy G RSC Adv. 2022; 10(3):1733-1756.
PMID: 35494673 PMC: 9048284. DOI: 10.1039/c9ra08706k.
A specific pharmacophore model of sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.
Tang C, Zhu X, Huang D, Zan X, Yang B, Li Y J Mol Model. 2011; 18(6):2795-804.
PMID: 22120948 DOI: 10.1007/s00894-011-1303-1.